BAY Stock Chart & Stats
zł205.30
zł0.00(0.00%)
At close: 4:00 PM EDT
zł205.30
zł0.00(0.00%)
Day’s Range― - ―
52-Week Rangezł75.00 - zł230.50
Previous CloseN/A
Volume0.00
Average Volume (3M)7.00
Market Cap
zł203.30B
Enterprise Valuezł71.97K
Total Cash (Recent Filing)zł6.66B
Total Debt (Recent Filing)zł38.89B
Price to Earnings (P/E)―
Beta0.53
Next Earnings
Nov 03, 2026EPS Estimate
2.26Next Dividend Ex-DateN/A
Dividend Yield0.23%
Share Statistics
EPS (TTM)-2.19
Shares Outstanding982,424,100
10 Day Avg. Volume10
30 Day Avg. Volume7
Financial Highlights & Ratios
PEG Ratio-0.24
Price to Book (P/B)1.40
Price to Sales (P/S)0.80
P/FCF Ratio17.45
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
zł243.30Price Target Upside18.51% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering8
EPS Forecast (FY)19.06
Revenue Forecast (FY)zł196.52B
Bulls Say, Bears Say
Bulls Say
Diversified Life‑science Business ModelBayer’s two large, distinct operating divisions (Pharmaceuticals and Crop Science) provide structural revenue diversification across healthcare and agriculture cycles. This reduces single-market dependency, smooths cash flow volatility, and supports cross‑business R&D and global distribution scale over the medium term.
Solid Underlying Operating MarginsSustained gross and operating margins indicate durable product-level profitability and pricing power across core portfolios. Strong underlying operating margins provide a buffer against cyclical revenue dips, support reinvestment into R&D and product launches, and improve the probability of restoring net profitability over the coming months.
Positive Cash Generation And Structural Deleveraging ActionPositive TTM operating and free cash flow combined with the announced €3.0bn minority stake sale into a LARC vehicle materially improves liquidity and reduces net financial debt. This strengthens the company’s ability to service debt, fund strategic initiatives, and execute the Five‑Year Framework without relying solely on volatile earnings.
Bears Say
High LeverageA debt-to-equity ratio near 1.3–1.4 indicates structurally elevated leverage that reduces financial flexibility. High fixed obligations increase sensitivity to earnings swings, constrain capital allocation to M&A or dividends, and make the balance sheet more vulnerable to prolonged revenue or cash‑flow weakness over the medium term.
Multi‑year Net Losses And Falling RevenueSustained negative net income and a multi‑year revenue decline weaken internal capital generation and impair return metrics. Without a clear, durable revenue turnaround, profit recovery may be slow, limiting organic deleveraging and raising dependence on asset sales or one‑time transactions to hit leverage targets.
Weakened Cash‑flow Momentum And Limited Debt CoverageAlthough FCF is positive, the sharp year‑over‑year slowdown and low coverage of total debt by operating cash indicate constrained deleveraging capacity. This reduces margin for error if operating results weaken further and limits the company’s ability to accelerate debt reduction while funding strategic investments.
Bayer News
BAY FAQ
What was Bayer’s price range in the past 12 months?
Bayer lowest stock price was zł75.00 and its highest was zł230.50 in the past 12 months.
What is Bayer’s market cap?
Bayer’s market cap is zł203.30B.
When is Bayer’s upcoming earnings report date?
Bayer’s upcoming earnings report date is Nov 03, 2026 which is in 90 days.
How were Bayer’s earnings last quarter?
Bayer released its earnings results on Aug 04, 2026. The company reported zł4.081 earnings per share for the quarter, beating the consensus estimate of zł3.303 by zł0.777.
Is Bayer overvalued?
According to Wall Street analysts Bayer’s price is currently Undervalued.
Does Bayer pay dividends?
Bayer pays a Annually dividend of zł0.474 which represents an annual dividend yield of 0.23%. See more information on Bayer dividends here
What is Bayer’s EPS estimate?
Bayer’s EPS estimate is 2.26.
How many shares outstanding does Bayer have?
Bayer has 982,424,100 shares outstanding.
What happened to Bayer’s price movement after its last earnings report?
Bayer reported an EPS of zł4.081 in its last earnings report, beating expectations of zł3.303. Following the earnings report the stock price went up 2.683%.
Which hedge fund is a major shareholder of Bayer?
Currently, no hedge funds are holding shares in PL:BAY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Bayer Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
zł243.30 (18.51% Upside)
zł243.30 (18.51% Upside)
Blogger Sentiment
Bullish
PL:BAY Sentiment 100%
Sector Average ―
Sector Average ―
Insider Transactions
Bought Shares
Worth zł12.4M over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
4.03%
12-Months-Change
Fundamentals
Return on Equity
0.23%
Trailing 12-Months
Asset Growth
-1.13%
Trailing 12-Months
Company Description
Bayer
Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment offers nonprescription over-the-counter medicines for self-medication and self-care; nutritional supplements; allergy, cough, and cold; dermatology; pain and cardiovascular risk prevention; and digestive health products. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solutions, and pest and weed management products, as well as customer services for agriculture. It also engages in the breeding, propagation, and production/processing of seeds, including seed dressing. The company distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen, Germany.
BAY Stock 12 Month Forecast
Average Price Target
zł243.30
▲(18.51% Upside)